Houston, TX -- (SBWIRE) -- 01/03/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.
Inovio Pharmaceuticals, Inc. (NYSE:INO) is currently trading at $0.500,0.62% lower. Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases. The Company's SynCon technology enables the design of universal vaccines capable of providing cross-protection against existing or changing strains of pathogens, such as influenza and human immunodeficiency virus (HIV). The Company's electroporation delivery technology uses brief, controlled electrical pulses to increase cellular uptake of the vaccine.
How Should Investors Trade INO After The Recent Volatile Moves? Find Out Here
ImmunoCellular Therapeutics Ltd (NYSE:IMUC) is higher 0.49% to $2.04. ImmunoCellular Therapeutics, Ltd. is a development-stage company. The Company is seeking to develop and commercialize new therapeutics to fight cancer using the immune system. The product candidate portfolio includes cellular immunotherapies targeting cancer and cancer stem cell antigens, peptide based immunotherapies targeting cancer stem cells, and monoclonal antibodies to diagnose and treat cancers such as glioblastoma multiforme, commonly (GBM), ovarian cancer, small-cell lung cancer and pancreatic cancer. Its product candidate, ICT-107, is a dendritic cell-based vaccine targeting multiple tumor associated antigens for GBM, a particularly lethal type of brain cancer.
Is IMUC Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here
YM BioSciences Inc. (USA) (NYSE:YMI) added 0.35% to $2.88. YM BioSciences Inc. (YM), is a drug development company. The Company is advancing three clinical-stage hematology and cancer-related products. Its CYT387, is an oral small molecule oral dual inhibitor of the JAK1/JAK2 kinase; nimotuzumab, an EGFR-targeting monoclonal antibody, and CYT997, a vascular disrupting agent (VDA). The Company conducts and outsources clinical trials and also out source the manufacture of clinical materials to third parties. It focuses to co-develop and/or license the rights to manufacture or market its products in development to other pharmaceutical companies in exchange for license fees and royalty payments.
Can YMI Rebound After The Recent Slump and Investors Can Make Money? Find Out Here
Dejour Energy Inc (USA) (NYSE:DEJ) among the gainers and the stock added 0.90% to $0.213. Dejour Energy Inc. (Dejour), formerly Dejour Enterprises Ltd. is engaged in the business of acquiring, exploring and developing energy projects with a focus on oil and gas exploration in Canada and the United States. The Company focuses on the oil and gas properties located in the United States and Canada. As of December 31, 2011, the Company held approximately 113,000 net acres of oil and gas leases in the Peace River Arch of northwestern British Columbia and northeastern Alberta, Canada and the Piceance, Paradox and Uinta Basins in the United States Rocky Mountains.
Is DEJ Ready To Move Back To New Highs This Year? Find Out Here
Vantage Drilling Company (NYSE:VTG) added 0.54% to $1.85. Vantage Drilling Company (Vantage Drilling) is an international offshore drilling company focused on operating a fleet of drilling units. The Company’s primary business is to contract drilling units, related equipment and work crews primarily on a dayrate basis to drill oil and natural gas wells for its customers. The Company also provides construction supervision services for, and will operate and manage, drilling units owned by others. Through its fleet of five wholly owned drilling units, the Company is a provider of offshore contract drilling services to oil and natural gas companies.
Is VTG Ready To Move Back To New Highs This Year? Find Out Here
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)